Journal of Clinical Oncology · 2006 · 228 citations · 26 references
MedicineOncologyPathologyCancer ImmunologyCellular PathologyImmunopathologyImmuno-oncology BiomarkersImmunohistochemistryLymph Node PathologyLymphoid NeoplasmsLymphoid TissueLymphoid Tissue PathologyDiagnostic ImmunohistochemistryDisease Prognostic BiomarkersForkhead Box ProteinsImmune Cell CompositionImmune MarkersLymphoma BiomarkersPrognostic BiomarkersTissue Microarrays
PURPOSE: To examine the immune microenvironment in diagnostic follicular lymphoma (FL) biopsies and evaluate its prognostic significance. PATIENTS AND METHODS: Immunohistochemistry was used to study numbers and location of cells staining positive for immune cell markers CD4, CD7, CD8, CD25, CD68, forkhead box protein P3 (FOXP3), T-cell intracellular antigen-1, and Granzyme B in tissue microarrays of paraffin-embedded, diagnostic lymph node biopsies taken from 59 FL patients who lived less than 5 years (short-survival group; n = 34) and more than 15 years (long-survival group; n = 25). RESULTS: CD4 and FOXP3 expression were significantly different between the two groups. Samples from the long-survival group were more likely than those from the short-survival group to have CD4+ staining cells and to have FOXP3-positive cells in a perifollicular location. CONCLUSION: This study has identified differences in immune cell composition of the diagnostic FL lymph node immune microenvironment and these have the potential for use as prognostic biomarkers in a routine histopathology setting.
26
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Juha Kononen, Lukas Bubendorf, Anne Kallionimeni et al. · Nature Medicine · 1998 · 4.1K citations
Follicular Lymphoma International Prognostic Index
Blood · 2004 · 1.5K citations · Full text
Medicine, Hematology, Oncology +16